Mortality Rates Among Patients With Schizophrenia and Tardive Dyskinesia
- 1 February 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 29 (1) , 5-8
Abstract
Tardive dyskinesia (TD) is a severe and potentially irreversible movement, and previous studies have suggested increased mortality among patients with TD, but most of these studies are limited by small sample sizes and short periods of follow-up. This study examined the mortality rate of a cohort of 608 Asian patients with schizophrenia during a 6-year period and used survival analyses on time from case ascertainment to outcome (death). Data on the survival status were collected and compared between those with and without TD, and cross-tabulation was performed to show the correlation between survival and mortality rates among patients with and without TD. Seventy-two patients died, 39 (54.2%) of whom had TD previously. Of the 536 surviving cases, 239 (44.6%) have TD. The mortality rates between those with TD and those without TD were statistically significant (hazard ratio, 2.62; 95% confidence interval, 1.58-4.33; P = 0.0006). The mortality rate was dependent on age; nevertheless, the adverse effect of TD on survival rate, although reduced, remains after controlling for age (hazard ratio, 1.90; 95% confidence interval, 1.12-3.20; P = 0.017). Our finding showed a robust association with increased mortality rate and TD, but we failed to find any significant association with any specific cause of death and TD.Keywords
This publication has 24 references indexed in Scilit:
- A Systematic Review of Mortality in SchizophreniaArchives of General Psychiatry, 2007
- Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East AsiaBritish Journal of Clinical Pharmacology, 2004
- Lower Risk for Tardive Dyskinesia Associated With Second-Generation Antipsychotics: A Systematic Review of 1-Year StudiesAmerican Journal of Psychiatry, 2004
- Consensus Development Conference on Antipsychotic Drugs and Obesity and DiabetesDiabetes Care, 2004
- Treatment of schizophrenia in low-income countriesInternational Journal of Neuropsychopharmacology, 1999
- Excess mortality of schizophreniaThe British Journal of Psychiatry, 1997
- The life expectancy of schizophrenic patients with tardive dyskinesiaHuman Psychopharmacology: Clinical and Experimental, 1992
- Mortality rate of schizophrenic patients with tardive dyskinesia during 10 years: A controlled study.The Keio Journal of Medicine, 1989
- Morbidity and mortality in tardive dyskinesia: associations in chronic schizophreniaActa Psychiatrica Scandinavica, 1987
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970